E-Cigarette Nicotine Delivery Among Young Adults by Nicotine Form, Concentration, and Flavor: A Crossover Randomized Clinical Trial
Concerns have been raised about the abuse liability of modern e-cigarettes that use acidic additives to form nicotine salts, making the inhalation of nicotine smoother than freebase nicotine. To examine the effects of nicotine form and concentration and e-liquid flavor on subjective effects ratings,...
Gespeichert in:
Veröffentlicht in: | JAMA network open 2024-08, Vol.7 (8), p.e2426702 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 8 |
container_start_page | e2426702 |
container_title | JAMA network open |
container_volume | 7 |
creator | Cho, Yoo Jin Mehta, Toral Hinton, Alice Sloan, Ruth Nshimiyimana, Jean Tackett, Alayna P Roberts, Megan E Brinkman, Marielle C Wagener, Theodore L |
description | Concerns have been raised about the abuse liability of modern e-cigarettes that use acidic additives to form nicotine salts, making the inhalation of nicotine smoother than freebase nicotine.
To examine the effects of nicotine form and concentration and e-liquid flavor on subjective effects ratings, vaping behavior, and nicotine uptake among young adults who use e-cigarettes.
In this single-blind, within-participant, crossover randomized clinical trial, a convenience sample of young adults aged 21 to 25 years who currently used e-cigarettes was recruited from December 2021 to August 2023, for in-person research laboratory visits in Columbus, Ohio.
Participants completed up to 9 vaping sessions, starting with their usual e-cigarette brand in the first session followed by 1 of 8 laboratory-prepared e-liquids in a randomly assigned order in each subsequent session. Prepared e-liquids varied by nicotine form (salt-based vs freebase), nicotine concentration (5% vs 1% weight per weight), and flavor (menthol vs tobacco). Each session included a 5-minute, 10-puff standardized vaping period followed by 30 minutes of ad libitum vaping.
At 4 time points (0, 5, 10, and 35 minutes) during each vaping session, plasma samples were collected for assessing nicotine uptake, and self-reports of urges, craving, and withdrawal were collected via questionnaires. Positive subjective effects were self-reported after 35 minutes of vaping using a visual analog scale; urges and cravings were reported using the Questionnaire of Smoking Urges (QSU). Puff topography data were collected throughout each vaping session.
Seventy-two participants (mean [SD] age, 22.4 [1.4] years; 42 [58.3%] female) who sampled at least 1 laboratory-prepared e-liquid composed the analytic sample. Salt-based (vs freebase) nicotine e-liquids increased nicotine intake, with 5% salt-based e-liquids delivering the highest mean plasma levels of nicotine (11.2 ng/mL [95% CI, 9.3-13.2 ng/mL] at 5 minutes; 17.2 ng/mL [95% CI, 14.3-20.1 ng/mL] at 35 minutes) irrespective of flavors. Higher positive subjective effect ratings (eg, for liking) were received by salt-based (42.8; 95% CI, 39.4-46.1) vs freebase (32.0; 95% CI, 28.6-35.3) nicotine, 1% (43.4; 95% CI, 40.2-46.6) vs 5% (31.2; 95% CI, 27.7-34.6) nicotine, and menthol-flavored (43.2; 95% CI, 39.7-46.7) vs tobacco-flavored (31.5; 95% CI, 28.4-34.7) e-liquids. Salt-based and 1% but not menthol-flavored nicotine elicited more intense puffing (eg, 25% [95% CI, 12%-40% |
doi_str_mv | 10.1001/jamanetworkopen.2024.26702 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11316233</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3142547036</sourcerecordid><originalsourceid>FETCH-LOGICAL-a295t-d274371a549660c131aa6c02901c0840498a39f86b4e2952341f93fad3acbea53</originalsourceid><addsrcrecordid>eNpdkU9v1DAQxSMEolXpV0AWXDg0y_hPkk0vaBW6tFIFEioHTtas4yxeHHtrJ4u2135xvN3Sll5sS_Pmed78suwdhQkFoB9X2KPTwx8ffvu1dhMGTExYWQF7kR2yohI5n0Lx8sn7IDuOcQUADCivy-J1dsBryqAGepjdnuWNWWLQw6DJV6P8YJwmn7U1Gx22ZNZ7tyQ__ZjOWTvaIZLF9lE396E_IY13Srsh4GC8OyHoWjK3uPHhlMxIE3yMPpmR76nge3OjW9JY44xCS66CQfsme9Whjfr4_j7KfszPrprz_PLbl4tmdpkjq4shb1kleEWxEHVZgqKcIpYKWMqhYCpA1FPkdTctF0KnBsYF7WreYctRLTQW_Cj7tPddj4tet_uZrVwH02PYSo9G_l9x5pdc-o2k6a-ScZ4cPtw7BH896jjI3kSlrU1I_BglT0utC6Cwk75_Jl35MbiUT3IqWCEq4GVSne5VaremoLuHaSjIHW_5jLfc8ZZ3vFPz26d5Hlr_0eV_AbfrrC0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3142547036</pqid></control><display><type>article</type><title>E-Cigarette Nicotine Delivery Among Young Adults by Nicotine Form, Concentration, and Flavor: A Crossover Randomized Clinical Trial</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Cho, Yoo Jin ; Mehta, Toral ; Hinton, Alice ; Sloan, Ruth ; Nshimiyimana, Jean ; Tackett, Alayna P ; Roberts, Megan E ; Brinkman, Marielle C ; Wagener, Theodore L</creator><creatorcontrib>Cho, Yoo Jin ; Mehta, Toral ; Hinton, Alice ; Sloan, Ruth ; Nshimiyimana, Jean ; Tackett, Alayna P ; Roberts, Megan E ; Brinkman, Marielle C ; Wagener, Theodore L</creatorcontrib><description>Concerns have been raised about the abuse liability of modern e-cigarettes that use acidic additives to form nicotine salts, making the inhalation of nicotine smoother than freebase nicotine.
To examine the effects of nicotine form and concentration and e-liquid flavor on subjective effects ratings, vaping behavior, and nicotine uptake among young adults who use e-cigarettes.
In this single-blind, within-participant, crossover randomized clinical trial, a convenience sample of young adults aged 21 to 25 years who currently used e-cigarettes was recruited from December 2021 to August 2023, for in-person research laboratory visits in Columbus, Ohio.
Participants completed up to 9 vaping sessions, starting with their usual e-cigarette brand in the first session followed by 1 of 8 laboratory-prepared e-liquids in a randomly assigned order in each subsequent session. Prepared e-liquids varied by nicotine form (salt-based vs freebase), nicotine concentration (5% vs 1% weight per weight), and flavor (menthol vs tobacco). Each session included a 5-minute, 10-puff standardized vaping period followed by 30 minutes of ad libitum vaping.
At 4 time points (0, 5, 10, and 35 minutes) during each vaping session, plasma samples were collected for assessing nicotine uptake, and self-reports of urges, craving, and withdrawal were collected via questionnaires. Positive subjective effects were self-reported after 35 minutes of vaping using a visual analog scale; urges and cravings were reported using the Questionnaire of Smoking Urges (QSU). Puff topography data were collected throughout each vaping session.
Seventy-two participants (mean [SD] age, 22.4 [1.4] years; 42 [58.3%] female) who sampled at least 1 laboratory-prepared e-liquid composed the analytic sample. Salt-based (vs freebase) nicotine e-liquids increased nicotine intake, with 5% salt-based e-liquids delivering the highest mean plasma levels of nicotine (11.2 ng/mL [95% CI, 9.3-13.2 ng/mL] at 5 minutes; 17.2 ng/mL [95% CI, 14.3-20.1 ng/mL] at 35 minutes) irrespective of flavors. Higher positive subjective effect ratings (eg, for liking) were received by salt-based (42.8; 95% CI, 39.4-46.1) vs freebase (32.0; 95% CI, 28.6-35.3) nicotine, 1% (43.4; 95% CI, 40.2-46.6) vs 5% (31.2; 95% CI, 27.7-34.6) nicotine, and menthol-flavored (43.2; 95% CI, 39.7-46.7) vs tobacco-flavored (31.5; 95% CI, 28.4-34.7) e-liquids. Salt-based and 1% but not menthol-flavored nicotine elicited more intense puffing (eg, 25% [95% CI, 12%-40%] more total puffs for nicotine salts vs freebase). All study e-liquids reduced urges and cravings, with 5% vs 1% nicotine being more effective (mean [SE] QSU-Desire score at 35 minutes, 15.4 [0.5] vs 16.7 [0.5]).
In this crossover randomized clinical trial among young adult e-cigarette users, salt-based (vs freebase) nicotine e-liquids increased nicotine intake and yielded more positive subjective effects ratings and intense puffing behaviors, suggesting higher abuse potential. Restricting the level of acidic additives and menthol flavoring may reduce the addictiveness of e-cigarettes.
ClinicalTrials.gov Identifier: NCT05458895.</description><identifier>ISSN: 2574-3805</identifier><identifier>EISSN: 2574-3805</identifier><identifier>DOI: 10.1001/jamanetworkopen.2024.26702</identifier><identifier>PMID: 39120901</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Adult ; Clinical trials ; Cross-Over Studies ; Electronic cigarettes ; Electronic Nicotine Delivery Systems - statistics & numerical data ; Female ; Flavoring Agents ; Humans ; Male ; Nicotine ; Nicotine - administration & dosage ; Online Only ; Original Investigation ; Public Health ; Single-Blind Method ; Vaping ; Young Adult ; Young adults</subject><ispartof>JAMA network open, 2024-08, Vol.7 (8), p.e2426702</ispartof><rights>2024. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright 2024 Cho YJ et al. .</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a295t-d274371a549660c131aa6c02901c0840498a39f86b4e2952341f93fad3acbea53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,861,882,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39120901$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cho, Yoo Jin</creatorcontrib><creatorcontrib>Mehta, Toral</creatorcontrib><creatorcontrib>Hinton, Alice</creatorcontrib><creatorcontrib>Sloan, Ruth</creatorcontrib><creatorcontrib>Nshimiyimana, Jean</creatorcontrib><creatorcontrib>Tackett, Alayna P</creatorcontrib><creatorcontrib>Roberts, Megan E</creatorcontrib><creatorcontrib>Brinkman, Marielle C</creatorcontrib><creatorcontrib>Wagener, Theodore L</creatorcontrib><title>E-Cigarette Nicotine Delivery Among Young Adults by Nicotine Form, Concentration, and Flavor: A Crossover Randomized Clinical Trial</title><title>JAMA network open</title><addtitle>JAMA Netw Open</addtitle><description>Concerns have been raised about the abuse liability of modern e-cigarettes that use acidic additives to form nicotine salts, making the inhalation of nicotine smoother than freebase nicotine.
To examine the effects of nicotine form and concentration and e-liquid flavor on subjective effects ratings, vaping behavior, and nicotine uptake among young adults who use e-cigarettes.
In this single-blind, within-participant, crossover randomized clinical trial, a convenience sample of young adults aged 21 to 25 years who currently used e-cigarettes was recruited from December 2021 to August 2023, for in-person research laboratory visits in Columbus, Ohio.
Participants completed up to 9 vaping sessions, starting with their usual e-cigarette brand in the first session followed by 1 of 8 laboratory-prepared e-liquids in a randomly assigned order in each subsequent session. Prepared e-liquids varied by nicotine form (salt-based vs freebase), nicotine concentration (5% vs 1% weight per weight), and flavor (menthol vs tobacco). Each session included a 5-minute, 10-puff standardized vaping period followed by 30 minutes of ad libitum vaping.
At 4 time points (0, 5, 10, and 35 minutes) during each vaping session, plasma samples were collected for assessing nicotine uptake, and self-reports of urges, craving, and withdrawal were collected via questionnaires. Positive subjective effects were self-reported after 35 minutes of vaping using a visual analog scale; urges and cravings were reported using the Questionnaire of Smoking Urges (QSU). Puff topography data were collected throughout each vaping session.
Seventy-two participants (mean [SD] age, 22.4 [1.4] years; 42 [58.3%] female) who sampled at least 1 laboratory-prepared e-liquid composed the analytic sample. Salt-based (vs freebase) nicotine e-liquids increased nicotine intake, with 5% salt-based e-liquids delivering the highest mean plasma levels of nicotine (11.2 ng/mL [95% CI, 9.3-13.2 ng/mL] at 5 minutes; 17.2 ng/mL [95% CI, 14.3-20.1 ng/mL] at 35 minutes) irrespective of flavors. Higher positive subjective effect ratings (eg, for liking) were received by salt-based (42.8; 95% CI, 39.4-46.1) vs freebase (32.0; 95% CI, 28.6-35.3) nicotine, 1% (43.4; 95% CI, 40.2-46.6) vs 5% (31.2; 95% CI, 27.7-34.6) nicotine, and menthol-flavored (43.2; 95% CI, 39.7-46.7) vs tobacco-flavored (31.5; 95% CI, 28.4-34.7) e-liquids. Salt-based and 1% but not menthol-flavored nicotine elicited more intense puffing (eg, 25% [95% CI, 12%-40%] more total puffs for nicotine salts vs freebase). All study e-liquids reduced urges and cravings, with 5% vs 1% nicotine being more effective (mean [SE] QSU-Desire score at 35 minutes, 15.4 [0.5] vs 16.7 [0.5]).
In this crossover randomized clinical trial among young adult e-cigarette users, salt-based (vs freebase) nicotine e-liquids increased nicotine intake and yielded more positive subjective effects ratings and intense puffing behaviors, suggesting higher abuse potential. Restricting the level of acidic additives and menthol flavoring may reduce the addictiveness of e-cigarettes.
ClinicalTrials.gov Identifier: NCT05458895.</description><subject>Adult</subject><subject>Clinical trials</subject><subject>Cross-Over Studies</subject><subject>Electronic cigarettes</subject><subject>Electronic Nicotine Delivery Systems - statistics & numerical data</subject><subject>Female</subject><subject>Flavoring Agents</subject><subject>Humans</subject><subject>Male</subject><subject>Nicotine</subject><subject>Nicotine - administration & dosage</subject><subject>Online Only</subject><subject>Original Investigation</subject><subject>Public Health</subject><subject>Single-Blind Method</subject><subject>Vaping</subject><subject>Young Adult</subject><subject>Young adults</subject><issn>2574-3805</issn><issn>2574-3805</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkU9v1DAQxSMEolXpV0AWXDg0y_hPkk0vaBW6tFIFEioHTtas4yxeHHtrJ4u2135xvN3Sll5sS_Pmed78suwdhQkFoB9X2KPTwx8ffvu1dhMGTExYWQF7kR2yohI5n0Lx8sn7IDuOcQUADCivy-J1dsBryqAGepjdnuWNWWLQw6DJV6P8YJwmn7U1Gx22ZNZ7tyQ__ZjOWTvaIZLF9lE396E_IY13Srsh4GC8OyHoWjK3uPHhlMxIE3yMPpmR76nge3OjW9JY44xCS66CQfsme9Whjfr4_j7KfszPrprz_PLbl4tmdpkjq4shb1kleEWxEHVZgqKcIpYKWMqhYCpA1FPkdTctF0KnBsYF7WreYctRLTQW_Cj7tPddj4tet_uZrVwH02PYSo9G_l9x5pdc-o2k6a-ScZ4cPtw7BH896jjI3kSlrU1I_BglT0utC6Cwk75_Jl35MbiUT3IqWCEq4GVSne5VaremoLuHaSjIHW_5jLfc8ZZ3vFPz26d5Hlr_0eV_AbfrrC0</recordid><startdate>20240801</startdate><enddate>20240801</enddate><creator>Cho, Yoo Jin</creator><creator>Mehta, Toral</creator><creator>Hinton, Alice</creator><creator>Sloan, Ruth</creator><creator>Nshimiyimana, Jean</creator><creator>Tackett, Alayna P</creator><creator>Roberts, Megan E</creator><creator>Brinkman, Marielle C</creator><creator>Wagener, Theodore L</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20240801</creationdate><title>E-Cigarette Nicotine Delivery Among Young Adults by Nicotine Form, Concentration, and Flavor: A Crossover Randomized Clinical Trial</title><author>Cho, Yoo Jin ; Mehta, Toral ; Hinton, Alice ; Sloan, Ruth ; Nshimiyimana, Jean ; Tackett, Alayna P ; Roberts, Megan E ; Brinkman, Marielle C ; Wagener, Theodore L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a295t-d274371a549660c131aa6c02901c0840498a39f86b4e2952341f93fad3acbea53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Clinical trials</topic><topic>Cross-Over Studies</topic><topic>Electronic cigarettes</topic><topic>Electronic Nicotine Delivery Systems - statistics & numerical data</topic><topic>Female</topic><topic>Flavoring Agents</topic><topic>Humans</topic><topic>Male</topic><topic>Nicotine</topic><topic>Nicotine - administration & dosage</topic><topic>Online Only</topic><topic>Original Investigation</topic><topic>Public Health</topic><topic>Single-Blind Method</topic><topic>Vaping</topic><topic>Young Adult</topic><topic>Young adults</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cho, Yoo Jin</creatorcontrib><creatorcontrib>Mehta, Toral</creatorcontrib><creatorcontrib>Hinton, Alice</creatorcontrib><creatorcontrib>Sloan, Ruth</creatorcontrib><creatorcontrib>Nshimiyimana, Jean</creatorcontrib><creatorcontrib>Tackett, Alayna P</creatorcontrib><creatorcontrib>Roberts, Megan E</creatorcontrib><creatorcontrib>Brinkman, Marielle C</creatorcontrib><creatorcontrib>Wagener, Theodore L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JAMA network open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cho, Yoo Jin</au><au>Mehta, Toral</au><au>Hinton, Alice</au><au>Sloan, Ruth</au><au>Nshimiyimana, Jean</au><au>Tackett, Alayna P</au><au>Roberts, Megan E</au><au>Brinkman, Marielle C</au><au>Wagener, Theodore L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>E-Cigarette Nicotine Delivery Among Young Adults by Nicotine Form, Concentration, and Flavor: A Crossover Randomized Clinical Trial</atitle><jtitle>JAMA network open</jtitle><addtitle>JAMA Netw Open</addtitle><date>2024-08-01</date><risdate>2024</risdate><volume>7</volume><issue>8</issue><spage>e2426702</spage><pages>e2426702-</pages><issn>2574-3805</issn><eissn>2574-3805</eissn><abstract>Concerns have been raised about the abuse liability of modern e-cigarettes that use acidic additives to form nicotine salts, making the inhalation of nicotine smoother than freebase nicotine.
To examine the effects of nicotine form and concentration and e-liquid flavor on subjective effects ratings, vaping behavior, and nicotine uptake among young adults who use e-cigarettes.
In this single-blind, within-participant, crossover randomized clinical trial, a convenience sample of young adults aged 21 to 25 years who currently used e-cigarettes was recruited from December 2021 to August 2023, for in-person research laboratory visits in Columbus, Ohio.
Participants completed up to 9 vaping sessions, starting with their usual e-cigarette brand in the first session followed by 1 of 8 laboratory-prepared e-liquids in a randomly assigned order in each subsequent session. Prepared e-liquids varied by nicotine form (salt-based vs freebase), nicotine concentration (5% vs 1% weight per weight), and flavor (menthol vs tobacco). Each session included a 5-minute, 10-puff standardized vaping period followed by 30 minutes of ad libitum vaping.
At 4 time points (0, 5, 10, and 35 minutes) during each vaping session, plasma samples were collected for assessing nicotine uptake, and self-reports of urges, craving, and withdrawal were collected via questionnaires. Positive subjective effects were self-reported after 35 minutes of vaping using a visual analog scale; urges and cravings were reported using the Questionnaire of Smoking Urges (QSU). Puff topography data were collected throughout each vaping session.
Seventy-two participants (mean [SD] age, 22.4 [1.4] years; 42 [58.3%] female) who sampled at least 1 laboratory-prepared e-liquid composed the analytic sample. Salt-based (vs freebase) nicotine e-liquids increased nicotine intake, with 5% salt-based e-liquids delivering the highest mean plasma levels of nicotine (11.2 ng/mL [95% CI, 9.3-13.2 ng/mL] at 5 minutes; 17.2 ng/mL [95% CI, 14.3-20.1 ng/mL] at 35 minutes) irrespective of flavors. Higher positive subjective effect ratings (eg, for liking) were received by salt-based (42.8; 95% CI, 39.4-46.1) vs freebase (32.0; 95% CI, 28.6-35.3) nicotine, 1% (43.4; 95% CI, 40.2-46.6) vs 5% (31.2; 95% CI, 27.7-34.6) nicotine, and menthol-flavored (43.2; 95% CI, 39.7-46.7) vs tobacco-flavored (31.5; 95% CI, 28.4-34.7) e-liquids. Salt-based and 1% but not menthol-flavored nicotine elicited more intense puffing (eg, 25% [95% CI, 12%-40%] more total puffs for nicotine salts vs freebase). All study e-liquids reduced urges and cravings, with 5% vs 1% nicotine being more effective (mean [SE] QSU-Desire score at 35 minutes, 15.4 [0.5] vs 16.7 [0.5]).
In this crossover randomized clinical trial among young adult e-cigarette users, salt-based (vs freebase) nicotine e-liquids increased nicotine intake and yielded more positive subjective effects ratings and intense puffing behaviors, suggesting higher abuse potential. Restricting the level of acidic additives and menthol flavoring may reduce the addictiveness of e-cigarettes.
ClinicalTrials.gov Identifier: NCT05458895.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>39120901</pmid><doi>10.1001/jamanetworkopen.2024.26702</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2574-3805 |
ispartof | JAMA network open, 2024-08, Vol.7 (8), p.e2426702 |
issn | 2574-3805 2574-3805 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11316233 |
source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Adult Clinical trials Cross-Over Studies Electronic cigarettes Electronic Nicotine Delivery Systems - statistics & numerical data Female Flavoring Agents Humans Male Nicotine Nicotine - administration & dosage Online Only Original Investigation Public Health Single-Blind Method Vaping Young Adult Young adults |
title | E-Cigarette Nicotine Delivery Among Young Adults by Nicotine Form, Concentration, and Flavor: A Crossover Randomized Clinical Trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T00%3A36%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=E-Cigarette%20Nicotine%20Delivery%20Among%20Young%20Adults%20by%20Nicotine%20Form,%20Concentration,%20and%20Flavor:%20A%20Crossover%20Randomized%20Clinical%20Trial&rft.jtitle=JAMA%20network%20open&rft.au=Cho,%20Yoo%20Jin&rft.date=2024-08-01&rft.volume=7&rft.issue=8&rft.spage=e2426702&rft.pages=e2426702-&rft.issn=2574-3805&rft.eissn=2574-3805&rft_id=info:doi/10.1001/jamanetworkopen.2024.26702&rft_dat=%3Cproquest_pubme%3E3142547036%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3142547036&rft_id=info:pmid/39120901&rfr_iscdi=true |